7 assets in Adrenal Gland Neoplasm

Therapeutic assets addressing Adrenal Gland Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Dexasone Adrenal Gland Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Floxuridine Adrenal Gland Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Nivolumab Adrenal Gland Neoplasm	Instituto do Cancer do Estado de São Paulo	P2	CCC (53)
pds01adc Adrenal Gland Neoplasm	National Cancer Institute (NCI)	P2	CCC (53)
Olaparib Adrenal Gland Neoplasm	Fundación de investigación HM	P1/2	CCC (48)
Oxodotreotide Adrenal Gland Neoplasm	Fundación de investigación HM	P1/2	CCC (48)
Idov-Immune Adrenal Gland Neoplasm	ViroMissile, Inc.	P1	CC (43)